XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows from Operating Activities    
Warrant derivative liability extinguished $ 373,070 $ 2,642,175
Net loss (2,751,787) (10,423,820)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 834,845 318,923
Bad debt expense 58,726 12,000
Gain on forgiveness of debt (24,925) 0
Equity based compensation expense 1,615,241 1,650,202
Recognized loss on marketable securities 534 18,740
Expenses paid through financings 0 32,500
Loan principal paid directly through grant (2,992) (5,964)
Amortization of debt discount and debt costs 2,486,111 214,885
Initial derivative expense 3,585,983 3,340,554
Change in derivative value due to anti-dilution adjustments 0 2,642,175
Change in fair value of derivative liability (8,203,371) 904,176
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (2,032,275) 19,964
Increase in accounts receivable - related parties (5,602) (10,115)
(Increase) decrease in prepaid expenses and other current assets (186,329) 269,051
Increase in accounts payable and accrued liabilities 1,900,033 (118,364)
Increase in accounts payable and accrued liabilities - related parties 410,040 103,723
Increase in other liabilities 0 49,554
Increase (decrease) in deferred revenue 425,383 (58,785)
Net cash used in operating activities (1,890,385) (1,040,601)
Cash Flows from Investing Activities    
Proceeds from sale of marketable securities 0 17,009
Cash and receivables acquired 220,153 0
Cash paid for acquisitions (249,983) 0
Net cash (used) provided by investing activities (29,830) 17,009
Cash Flows from Financing Activities    
Proceeds from notes 250,000 398,545
Proceeds from convertible notes 2,153,200 2,226,000
Deferred offering costs (473,896) 0
Payments of notes (11,193) (7,396)
Advances on receivables 0 180,778
Repayments of advances on receivables 0 (112,622)
Repayments of sale of future revenues (10,904) (261,866)
Deposit on purchase of preferred stock 0 25,000
Net cash provided by financing activities 1,907,207 2,448,439
Net increase (decrease) in cash (13,008) 1,424,847
Cash, beginning of period 99,906 306,252
Cash, end of period 86,898 1,731,099
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 159,325 86,438
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Original issue discount deducted from convertible note proceeds 342,554 328,125
Debt costs deducted from convertible note proceeds 334,800 366,500
Intangible assets acquired 7,066,165 0
Notes and accrued interest converted to common stock 356,689 0
Common stock issued/to be issued for asset acquisitions 4,956,948 0
Notes payable and accrued interest exchanged for debentures 252,430 0
Accounts payable paid with common stock 140,000 0
Accrued compensation paid with common stock 16,425 0
Liabilities assumed in acquisition 89,089 0
Warrant derivative liability at inception 5,960,059 5,625,519
Preferred stock issued for accrued penalties $ 0 $ 1,929,516